Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.

BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve Raising of Funds through issuance of Commercial ...

India's Finance Minister will present the FY25-26 Union Budget on February 1, 2025. Analysts suggest focus on manufacturing, ...

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

The agency launched an investigation into Alphabet Inc's Google in 2022 on suspicion it had abused its dominant position by ...

Here's a list of buy/sell recommendations for today from three analysts: Ankush Bajaj, Raja Venkatraman, and MarketSmith ...

The Nity50 opened with a significant gap up of 102 points at 23,306.20. However, sellers intervened and pulled the index down ...

As the US remains the top market for the Indian pharmaceutical industry, experts in India are now expecting opportunities for ...

Josh Gissing is Cluster Head (UK, Ireland & Nordics) for Biocon Biologics: a biosimilars company whose business model seeks ...